MYCAMINE subst sèche 50 mg flac

7680607240011 CH-60724 J02AX05 08.06.0.

Reimbursement limitations:

MYCAMINE2

Mycamine n’est remboursé que lorsque les autres antifongiques systémiques tels que les azolés ou une …

MYCAMINE subst sèche 50 mg flac
MYCAMINE subst sèche 50 mg flac
MYCAMINE subst sèche 50 mg flac
1 / 3
google

Details

Product number
6072401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: micafunginum 50 mg ut micafunginum natricum, lactosum monohydricum, acidum citricum, natrii hydroxidum, pro vitro corresp. natrium max. 1 mg.

Articles (1)

Mycamine 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/01/2025
Professional SmPC
Français
25/01/2025
Professional SmPC
Italien
25/01/2025

Detailed composition

Substance Quantity Type Category
PRC
50.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance WIZUS
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HBESI

Reimbursement information

Public price
CHF 292.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2014

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
60724
Drug name
Mycamine, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
J02AX05
Authorization status
Z
Dispensation category
A
First authorization
11/07/2012
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Packaging details

Description (FR)
MYCAMINE subst sèche 50 mg flac
Description (DE)
MYCAMINE Trockensub 50 mg Durchstf
Market launch
11/07/2012
Narcotic (BTM)
No

Other packaging sizes

MYCAMINE subst sèche 100 mg flac
1 DUR
View